Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics

Hims & Hers Health, Inc. (HIMS): $14.60

0.05 (+0.34%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

A

Add HIMS to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#30 of 69

in industry

HIMS Price/Volume Stats

Current price $14.60 52-week high $17.16
Prev. close $14.55 52-week low $5.65
Day low $14.43 Volume 2,974,800
Day high $14.75 Avg. volume 4,667,463
50-day MA $12.94 Dividend yield N/A
200-day MA $8.96 Market Cap 3.13B

HIMS Stock Price Chart Interactive Chart >


Hims & Hers Health, Inc. (HIMS) Company Bio


Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.


HIMS Latest News Stream


Event/Time News Detail
Loading, please wait...

HIMS Latest Social Stream


Loading social stream, please wait...

View Full HIMS Social Stream

Latest HIMS News From Around the Web

Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

SAN FRANCISCO, December 04, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today unveiled Weight Loss by Hims & Hers, a comprehensive and customizable clinical approach specifically designed to help people achieve their individual weight-loss goals. The company also announced that Craig Primack, MD, FACP, FAAP, FOMA, a pioneer in the field of clinical obesity medicine, has joined the company as SVP of Weight Management.

Yahoo | December 4, 2023

5 Telehealth Stocks That Have Nothing But Upside

Navigate the exciting world of telehealth with our curated list of top telehealth stocks.

Faizan Farooque on InvestorPlace | November 26, 2023

It Is Time To Buy Hims & Hers Stock

Hims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component.

TalkMarkets.com | November 24, 2023

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy

Jeremy Flint on InvestorPlace | November 23, 2023

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023.

Yahoo | November 6, 2023

Read More 'HIMS' Stories Here

HIMS Price Returns

1-mo -3.44%
3-mo 70.36%
6-mo 133.60%
1-year 45.27%
3-year 20.46%
5-year N/A
YTD 64.04%
2023 38.85%
2022 -2.14%
2021 -55.14%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!